Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02119390 · ClinicalTrials.gov registry record · NA

Medication Adherence in Human Immunodeficiency Virus (HIV)

A NA study, sponsored by St. Jude Children's Research Hospital.

Completed
Registry status
NA
Development phase
33
Enrollment target

NCT02119390 is a NA study that has completed, run by St. Jude Children's Research Hospital. The registered enrollment target is 33 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02119390, a NA study, has completed, sponsored by St. Jude Children's Research Hospital.

COMPLETED
Registry status
NA
Development phase
33 participants
Enrollment target

Study Summary

Although effective treatments are currently available to treat human immunodeficiency virus (HIV), the retrovirus leading to acquired immune deficiency syndrome (AIDS), strict adherence to the treatment regimen is required. Nonadherence to highly active antiretroviral therapy (HAART) regimens is well documented in individuals with HIV. This is especially true for adolescents and young adults (AYA), where rates of adherence range from 20 to 100%. Nonadherence has significant implications for subsequent treatment response and health outcomes, including poor virologic response, development of drug resistance, and mortality. Of note, previous research has suggested that every 1% increase in nonadherence is related to a 2% increased likelihood of detectable viral load (VL) in youth with behaviorally acquired HIV. Furthermore, higher VL is the most salient variable related to increased risk of virus transmission. Thus, nonadherence to HAART is a significant public health issue. The objective of the proposed research plan is to systematically examine an individualized, behavioral intervention targeting HAART nonadherence in AYAs initiating HAART. The current intervention will support AYA participation in brief, staff-delivered instruction in adherence-promotion skills. Individualized behavioral analysis and motivational interviewing will be applied to provide effective solutions for current barriers to HAART adherence before and after HAART initiation, as recommended by the Panel on Antiretroviral Guidelines for Adults and Adolescents.

Interventions

  • OTHER Questionnaires
  • BEHAVIORAL Staff-delivered intervention sessions
  • OTHER Demographic Questionnaire

Trial Details

FieldValue
Enrollment Target 33 participants
Start Date 2014-04
Est. Completion 2016-07
Phase NA

What the Registry Record Tells You About NCT02119390

The ClinicalTrials.gov registry entry for NCT02119390 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is St. Jude Children's Research Hospital, which has 410 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 3 interventions - of which Questionnaires is the first listed.

NCT02119390 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02119390 about?

NCT02119390 is a clinical study titled "Medication Adherence in Human Immunodeficiency Virus (HIV)". Although effective treatments are currently available to treat human immunodeficiency virus (HIV), the retrovirus leading to acquired immune deficiency syndrome (AIDS), strict adherence to the treatment regimen is required. Nonadherence to highly active antiretroviral therapy (HAART) regimens is wel...

What is the current status of trial NCT02119390?

This trial is currently completed. It is a NA study. The enrollment target is 33 participants. The study started on 2014-04. Estimated completion is 2016-07.

What interventions are being tested in trial NCT02119390?

The interventions under investigation include: Questionnaires (OTHER), Staff-delivered intervention sessions (BEHAVIORAL), Demographic Questionnaire (OTHER).

Who is sponsoring clinical trial NCT02119390?

This trial is sponsored by St. Jude Children's Research Hospital, which has 410 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.